ORCHA and Alpha MD Forge Strategic Partnership to Revolutionise Digital Health Delivery in India

Leaders in Digital Health Join Forces to Introduce Groundbreaking Products

New Delhi (India), January 15: ORCHA, the Organisation for the Review of Health and Care Apps, and Alpha MD, a leading player in healthcare innovation, are proud to announce a strategic partnership aimed at shaping and supporting digital health delivery in India. The collaboration will kick off with the launch of the ORCHA India Data Protection Mark (OIDPM), the first in a series of pioneering products set to transform the landscape of digital health in India.

Digital health is at the forefront of the healthcare revolution, providing innovative solutions that have the power to redefine patient care and outcomes. However, to fully harness the potential of these technologies, trust and compliance are paramount. The OIDPM, a brainchild of the ORCHA-Alpha MD partnership, is specifically designed to address these critical aspects.

The OIDPM is an introductory assessment that evaluates digital health products against over 100 review points, ensuring compliance with the Digital Personal Data Protection Act 2023. This rapid, independent, and objective assessment provides digital health innovators with a clear understanding of their product’s compliance status. Successful assessment will grant innovators an approved badge and a badge of excellence that opens doors to inclusion in the ORCHA Alpha MD compliance portal.

Key benefits of the ORCHA Alpha MD Partnership:

  1. Comprehensive digital health assessment: The OIDPM sets the stage for a series of groundbreaking products aimed at transforming the digital health landscape in India.
  2. Rapid, objective and independent evaluation: Digital health technologies undergo a thorough assessment within 20 days, providing innovators with timely insights into their product’s compliance with data protection regulations.
  3. Global Industry Standards Compliance: The OIDPM not only aligns with Indian regulations but draws on the Data Privacy section of the ORCHA Baseline Review which covers over 350 review points used within 70% of global industry standards, giving innovators a broader perspective on their product’s performance globally.
  4. Recognition of Excellence: Successful assessment grants innovators an approved badge, a symbol of high quality and compliance that facilitates trust among health and care professionals.
  5. Market Growth Opportunities: Inclusion in compliance portals will open doors to market growth opportunities, allowing DPDPA compliant digital health products to be seamlessly integrated into healthcare systems across India.

Quote from Liz Ashall-Payne, CEO, ORCHA:

“As leaders in digital health, ORCHA is excited to partner with Alpha MD to set a new gold standard in healthcare technology standards for India. The ORCHA India Data Protection Mark (OIDPM) signifies our commitment to robust data protection and excellence, positioning Indian healthcare apps for global recognition. This strategic partnership revolutionises digital health assessment, fostering tr’ust and confidence in India’s health ecosystem and is entirely aligned to the values underpinning ORCHA itself.” 

Quote from Jiggs Barasara, CEO, Alpha MD

“The Alpha MD and ORCHA partnership is pivotal, fortifying Indian healthcare apps for the evolving landscape of healthcare technology standards. This strategic partnership ensures robust data protection and positions these applications for global recognition, setting the gold standard for India’s health ecosystem.”

Quote from Harjinder Kang, His Majesty’s Trade Commissioner and Western India Deputy High Commissioner 

Digital Technology has transformed our lives and will continue scaling in the future, with data being the driving force.

It is great to see this partnership between UK and India implementing new standards for healthcare technology, thereby further revolutionising Indian healthcare apps in the global order.

Contact:

Fiona Costello                                                Nishi Sharma

SVP Assurance Services, ORCHA              AVP Digital Governance, Alpha MD

[email protected]                 [email protected]

About ORCHA

ORCHA is a global leader in digital health technology assurance and activation, helping healthcare professionals, commissioners, and the public to discover health apps that can make a positive impact on health outcomes. The ORCHA Assure platform is used by organisations around the world to support the identification, assurance and implementation of safe and effective digital health technologies.

About Alpha MD

Alpha MD delivers cutting-edge products that empower patients, caregivers, and stakeholders in their healthcare journey. Our diverse range of offerings also supports companies in navigating the complex healthcare and life sciences landscape, fostering advancements in India and beyond.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More